Elevation Spine, a developer of integrated-fixation spinal technologies, on Sept. 22 completed its Series B preferred stock financing, totaling $11 million.
The funding was led by Technology Venture Partners and included participation from Mutual Capital Partners and existing investors. Elevation Spine also appointed Donald Bossi and Bryson Hollimon, both of Technology Venture Partners, to its board.
Elevation Spine CEO Charles Gilbride said the company will use the funding to build out a full commercial team and expand the use of its Saber-C system for spinal fusions.
"Saber Technology is an important advancement in spinal fusion technologies," Mr. Bossi said in a Sept. 22 news release. "It allows surgeons to access hard-to-reach areas of the spine more easily and with fewer procedural steps. This differentiated technology provides significant advantages to the surgeon and the patient over current technologies and has a very exciting future.”